These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15277984)

  • 1. Somatic mutations in peroxisome proliferator-activated receptor-gamma are rare events in human cancer cells.
    Posch MG; Zang C; Mueller W; Lass U; von Deimling A; Elstner E
    Med Sci Monit; 2004 Aug; 10(8):BR250-4. PubMed ID: 15277984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.
    Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scalissi N; Speranza AC; Hirata MH
    Diabetes Obes Metab; 2005 Sep; 7(5):605-11. PubMed ID: 16050954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
    Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG
    J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor- gamma expression in human malignant and normal brain, breast and prostate-derived cells.
    Nwankwo JO; Robbins ME
    Prostaglandins Leukot Essent Fatty Acids; 2001; 64(4-5):241-5. PubMed ID: 11418018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture.
    Fröhlich E; Machicao F; Wahl R
    Endocr Relat Cancer; 2005 Jun; 12(2):291-303. PubMed ID: 15947104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma in malignant diseases.
    Wang T; Xu J; Yu X; Yang R; Han ZC
    Crit Rev Oncol Hematol; 2006 Apr; 58(1):1-14. PubMed ID: 16388966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
    Xiao J; Leung JC; Chan LY; Guo H; Lai KN
    Nephrol Dial Transplant; 2009 Jul; 24(7):2067-77. PubMed ID: 19155534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
    Eucker J; Sterz J; Krebbel H; Zavrski I; Kaiser M; Zang C; Heider U; Jakob C; Elstner E; Sezer O
    Anticancer Drugs; 2006 Aug; 17(7):763-9. PubMed ID: 16926626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations.
    Haitian Z; Yunfei L; Jian Z; Jian L; Qinghua L; Fuqiang W
    Breast; 2008 Dec; 17(6):563-7. PubMed ID: 18835712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ; Liu PQ; Lin DJ; Xiao RZ; Huang M; Li XD; He Y; Huang RW
    Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor expression and activation in normal human colonic epithelial cells and tubular adenomas.
    Matthiessen MW; Pedersen G; Albrektsen T; Adamsen S; Fleckner J; Brynskov J
    Scand J Gastroenterol; 2005 Feb; 40(2):198-205. PubMed ID: 15764152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
    Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?
    Han S; Roman J
    Anticancer Drugs; 2007 Mar; 18(3):237-44. PubMed ID: 17264754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
    Duan SZ; Usher MG; Mortensen RM
    Circ Res; 2008 Feb; 102(3):283-94. PubMed ID: 18276926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Takashima T; Fujiwara Y; Hamaguchi M; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Higuchi K; Arakawa T
    Oncol Rep; 2005 Apr; 13(4):601-6. PubMed ID: 15756430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
    Burton JD; Castillo ME; Goldenberg DM; Blumenthal RD
    Anticancer Drugs; 2007 Jun; 18(5):525-34. PubMed ID: 17414621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a peroxisome proliferator-activated receptor gamma 1 splice variant that was identified in human lung cancers suppresses cell death induced by cisplatin and oxidative stress.
    Kim HJ; Hwang JY; Kim HJ; Choi WS; Lee JH; Kim HJ; Chang KC; Nishinaka T; Yabe-Nishimura C; Seo HG
    Clin Cancer Res; 2007 May; 13(9):2577-83. PubMed ID: 17473186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism, Helicobacter pylori infection and non-cardia gastric carcinoma in Chinese.
    Liao SY; Zeng ZR; Leung WK; Zhou SZ; Chen B; Sung JJ; Hu PJ
    Aliment Pharmacol Ther; 2006 Jan; 23(2):289-94. PubMed ID: 16393309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markers.
    Yee LD; Williams N; Wen P; Young DC; Lester J; Johnson MV; Farrar WB; Walker MJ; Povoski SP; Suster S; Eng C
    Clin Cancer Res; 2007 Jan; 13(1):246-52. PubMed ID: 17200362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.